Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidine

被引：12

作者：

El-Metwally, Souad A. ^{[1
]}

Elkady, Hazem ^{[2
]}

Hagras, Mohamed ^{[3
]}

Elkaeed, Eslam B. ^{[4
]}

Alsfouk, Bshra A. ^{[5
]}

Doghish, Ahmed S. ^{[6
,7
]}

Ibrahim, Ibrahim M. ^{[8
]}

Taghour, Mohammed S. ^{[2
]}

Husein, Dalal Z. ^{[9
]}

Metwaly, Ahmed M. ^{[10
,11
]}

Eissa, Ibrahim H. ^{[1
]}

机构：

[1] Higher Technol Inst, Dept Basic Sci, 10th Ramadan City, Egypt

[2] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt

[3] Al Azhar Univ, Coll Pharm, Dept Pharmaceut Organ Chem, Cairo 11884, Egypt

[4] AlMaarefa Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh 13713, Saudi Arabia

[5] Princess Nourah bint Abdulrahman Univ, Coll Pharm, Dept Pharmaceut Sci, POB 84428, Riyadh 11671, Saudi Arabia

[6] Badr Univ Cairo BUC, Fac Pharm, Dept Biochem, Cairo 11829, Egypt

[7] Al Azhar Univ, Fac Pharm Boys, Biochem & Mol Biol Dept, Cairo 11231, Egypt

[8] Cairo Univ, Fac Sci, Biophys Dept, Cairo 12613, Egypt

[9] New Valley Univ, Fac Sci, Chem Dept, El Kharja 72511, Egypt

[10] Al Azhar Univ, Fac Pharm Boys, Pharmacognosy & Med Plants Dept, Cairo 11884, Egypt

[11] Genet Engn & Biotechnol Res Inst, Biopharmaceut Prod Res Dept, City Sci Res & Technol Applicat SRTA City, Alexandria, Egypt

来源：

FUTURE MEDICINAL CHEMISTRY | 2023年 / 15卷 / 22期

关键词：

apoptosis; docking; MD simulations; thieno[2,3-d]pyrimidine; VEGFR-2; IN-SILICO; MOLECULAR DOCKING; CELL-LINES; DESIGN; DERIVATIVES; TOXICITY; ADMET; ANTICANCER; VITRO; ANGIOGENESIS;

D O I：

10.4155/fmc-2023-0130

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Background: VEGFR-2 is a key regulator of cancer cell proliferation, migration and angiogenesis. Aim: Development of thieno[2,3-d]pyrimidine derivatives as potential anti-cancer agents targeting VEGFR-2. Methods: Seven in vitro and nine in silico studies were conducted. Results: Compound 10d demonstrated strong anticancer potential, boosting apoptosis based on VEGFR-2 inhibition. It arrested the S phase of the cell cycle and upregulated the apoptotic factors. Docking and molecular dynamics simulation studies confirm the stability of the VEGFR-2-10d complex and suggest that these compounds have good binding affinities to VEGFR-2. In addition, the drug-likeness was confirmed. Conclusion: Thieno[2,3-d]pyrimidines, particularly compound 10d, has good anticancer effects and may contribute to the development of new anticancer therapies.

引用

页码：2065 / 2086

页数：22

共 50 条

[1] Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents
El-Metwally, Souad A.
Abou-El-Regal, Mohsen M.
Eissa, Ibrahim H.
Mehany, Ahmed B. M.
Mahdy, Hazem A.
Elkady, Hazem
Elwan, Alaa
Elkaeed, Eslam B.
BIOORGANIC CHEMISTRY, 2021, 112
[2] New Thieno[2,3-d]pyrimidines as Anticancer VEGFR-2 Inhibitors with Apoptosis Induction: Design, Synthesis, and Biological and In Silico Studies
Sobh, Eman A.
Dahab, Mohammed A.
Elkaeed, Eslam B.
Alsfouk, Bshra A.
Ibrahim, Ibrahim M.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
MEDICINAL CHEMISTRY, 2024, 20 (09) : 876 - 899
[3] New modified thieno[2,3-d]pyrimidine derivatives as VEGFR-2 inhibitors: Design, synthesis, in vitro anti-cancer evaluation and divers in silico studies
El-Metwally, Souad A.
Omara, Mariam
Elkady, Hazem
Elkaeed, Eslam B.
Al-ghulikah, Hanan A.
Taghour, Mohammed S.
El-Mahdy, Hesham A.
Ibrahim, Ibrahim M.
Husein, Dalal Z.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
JOURNAL OF MOLECULAR STRUCTURE, 2024, 1302
[4] Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers
Abd El-Mawgoud, Heba K.
AboulMagd, Asmaa M.
Nemr, Mohamed T. M.
Hemdan, Magdy M.
Hassaballah, Aya I.
Farag, Paula S.
BIOORGANIC CHEMISTRY, 2024, 150
[5] In vitro and in silico evaluation of new thieno[2,3-d]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2
El-Metwally, Souad A.
Abuelkhir, Abdelrahman A.
Elkady, Hazem
Taghour, Mohammed S.
Ibrahim, Ibrahim M.
Husein, Dalal Z.
Alsfouk, Aisha A.
Sultan, Ahlam
Ismail, Ahmed
Elkhawaga, Samy Y.
Elkaeed, Eslam B.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2023, 106
[6] Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations
Elrazaz, Eman Z.
Serya, Rabah A. T.
Ismail, Nasser S. M.
Albohy, Amgad
Abou El Ella, Dalal A.
Abouzid, Khaled A. M.
BIOORGANIC CHEMISTRY, 2021, 113
[7] Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno [2,3-d]pyrimidines targeting VEGFR-2
El-Metwally, Souad A.
Elkady, Hazem
Hagras, Mohamed
Husein, Dalal Z.
Ibrahim, Ibrahim M.
Taghour, Mohammed S.
El-Mahdy, Hesham A.
Ismail, Ahmed
Alsfouk, Bshra A.
Elkaeed, Eslam B.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
RSC ADVANCES, 2023, 13 (33) : 23365 - 23385
[8] Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking
Hassan, Rasha A.
Hamed, Mohammed I. A.
Abdou, Amr M.
El-Dash, Yara
BIOORGANIC CHEMISTRY, 2022, 125
[9] Anti-breast cancer potential of thieno-pyrimidine derivatives as VEGFR-2 inhibitors
Alsfouk, Aisha A.
Al Ward, Maged Mohammed Saleh
Al-Qadhi, Mustafa A.
El-Metwally, Souad A.
Yousef, Reda G.
Elkaeed, Eslam B.
Husein, Dalal Z.
Amin, Fatma G.
Elkady, Hazem
Metwaly, Ahmed M.
Eissa, Ibrahim H.
FUTURE MEDICINAL CHEMISTRY, 2025, : 803 - 818
[10] Discovery of new thieno[2,3-d]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatment
Sobh, Eman A.
Dahab, Mohammed A.
Elkaeed, Eslam B.
Alsfouk, Aisha A.
Ibrahim, Ibrahim M.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
FUTURE MEDICINAL CHEMISTRY, 2023, 15 (13) : 1167 - 1184

← 1 2 3 4 5 →